Background: Allergic rhinitis (AR) is a worldwide health problem with rising prevalence. To enhance the estimation of AR prevalence in epidemiological studies, the Score for AR (SFAR), a screening tool, has been developed and widely used. An 8-item SFAR is a handy, self-administered instrument assessing the information on nasal and eye symptoms, seasonal increase in symptoms, skin test results, and previous AR diagnoses. This study aimed to adapt the SFAR to the Chinese population (CSFAR) and validate it by testing its psychometric properties and diagnostic accuracy. Methods: This methodological study involved translation and validation phases. Different batches of participants were recruited for the above purposes. Results: In phase 1, the CSFAR obtained satisfactory item (80-100%) and scale level (97.8%) semantic equivalence, content validity index (96.7%), comprehensibility (100%), cross-language testing (κ = 0.44-0.83 for item-to-item agreement; intraclass correlation coefficient [ICC] = 0.95, p < 0.05-0.001). In phase 2, CSFAR showed satisfactory internal consistency (α = 0.83), 1-month (ICC = 0.88) and 1-year stability (ICC = 0.85), and construct validity (significant correlation between CSFAR and impairments induced by AR: r = 0.47, p < 0.001). Based on the receiver-operating characteristic curve, comparing the CSFAR with diagnosis made by specialists, an optimal cutoff value was 6 (sensitivity 81.8% and specificity 80.3%). Conclusion: SFAR was translated into a Chinese version, the CSFAR. Satisfactory results were obtained for its equivalence, appropriateness, comprehensibility, and relevance, as well as its reliability and validity. A cutoff value of 6 was recommended to increase the diagnostic accuracy in environments with less pollen. This study provides evidence that the SFAR we adapted for the Chinese population is a valuable tool in AR screening.

Keywords:
Allergic rhinitis, Adaptation, Chinese population, Validation, Psychometric testing
1.
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63:8-160.
2.
Koinis-Mitchell D, Craig T, Esteban CA, Klein RB: Sleep and allergic disease: a summary of the literature and future directions for research. J Allergy Clin Immunol 2012;130:1275-1281.
3.
Meltzer EO, Blaiss MS, Derebery MJ, Mahr TA, Gordon BR, Sheth KK, Simmons AL, Wingertzahn MA, Boyle JM: Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 2009;124:S43-S70.
4.
Brożek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ: Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-476.
5.
Wong GWK, Leung TF, Ko FWS: Changing prevalence of allergic diseases in the Asia- Pacific region. Allergy. Asthma Immunol Res 2013;5:251-257.
6.
Katelaris CH, Lai CKW, Rhee C-S, Quang VT, Hwang J, Singh H, Kim J, Boyle JM, Dhong HJ, Narayanan P, Vicente G, Blaiss M, Sacks R: Nasal allergies in the Asian-Pacific population: results from the Allergies in Asia-Pacific Survey. Am J Rhinol Allergy 2011;25:3-15.
7.
Lamb CE, Ratner PH, Johnson CE, Ambegaonkar AJ, Joshi AV, Day D, Eng B: Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006;22:1203-1210.
8.
Hemp P: Presenteeism: at work - but out of it. Havard Bus Rev 2004;82:49-58.
9.
Ng DK, Chan CH, Hwang GYY, Chow PY, Kwok KL: A review of the roles of allergic rhinitis in childhood obstructive sleep apnea syndrome. Allergy Asthma Proc 2006;27:240-242.
10.
Lau YL, Karlberg J: Prevalence and risk factors of childhood asthma, rhinitis and eczema in Hong Kong. J Paediatr Child Health 1998;34:47-52.
11.
Lee SL, Wong W, Lau YL: Increasing prevalence of allergic rhinitis but not asthma among children in Hong Kong from 1995 to 2001 (Phase 3 International Study of Asthma and Allergies in Childhood). Pediatr Allergy Immunol 2004;15:72-78.
12.
Beasley R: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-1232.
13.
Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Stewart AW: International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483-491.
14.
Kim H, Levin L, LeMasters GK, Villareal M, Evans S, Lockey JE, Bernstein DI: Validating childhood symptoms with physician-diagnosed allergic rhinitis. Ann Allergy Asthma Immunol 2012;108:228-231.
15.
Piau JP, Massot C, Moreau D, Ait-Khaled N, Bouayad Z, Mohammad Y, M'boussa J: Assessing allergic rhinitis in developing countries. Int J Tuberc Lung Dis 2010;14:506-512.
16.
Annesi-Maesano I, Didier A, Klossek M, Chanal I, Moreau D, Bousquet J: The Score for Allergic Rhinitis (SFAR): a simple and valid assessment method in population studies. Allergy 2002;57:107-114.
17.
Charpin D, Sibbald B, Weeke E, Wüthrich B: Epidemiologic identification of allergic rhinitis. Allergy 1996;51:293-298.
18.
Eriksson NE: Allergy screening with Phadiatop® and CAP Phadiatop® in combination with a questionnaire in adults with asthma and rhinitis. Allergy 1990;45:285-292.
19.
Kauppi P, Laitinen LA, Laitinen H, Kere J, Laitinen T: Verification of self-reported asthma and allergy in subjects and their family members volunteering for gene mapping studies. Respir Med 1998;92:1281-1288.
20.
Kilpeläinen M, Terho EO, Helenius H, Koskenvuo M: Validation of a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults. Allergy 2001;56:377-384.
21.
Gendo K, Larson EB: Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med 2004;140:278-289.
22.
Lindberg S, Malm L: Comparison of allergic rhinitis and vasomotor rhinitis patients on the basis of a computer questionnaire. Allergy 1993;48:602-607.
23.
Cingi C, Songu M, Ural A, Annesi-Maesano I, Erdogmus N, Bal C, Ozlugedik S: The Score for Allergic Rhinitis study in Turkey. Am J Rhinol Allergy 2011;25:333-337.
24.
Ologe FE, Adebola SO, Dunmade AD, Adeniji KA, Oyejola BA: Symptom Score for Allergic Rhinitis. Otolaryngol Head Neck Surg 2013;148:557-563.
25.
Di R, Lou X, Ye L, Miao J, Zhao Y: Prevalence of allergic rhinitis and its effect on the quality of life of middle school students. Int J Clin Exp Med 2016;9:15772-15779.
26.
Yu MF, Lu WA: Correlation study of the Score for Allergic Rhinitis and clinical course in adolescence of Yilan county. Taipei Res Tradit Chin Med J 2013;16:149-168.
27.
Brislin RW: The wording and translation of research instrument; in Lonner WJ, Berry JW (eds): Field Methods in Cross-Cultural Research. Beverley Hills, Sage, 1986, pp 137-164.
28.
Wong CL, Ip WY, Shiu TY: Translation and validation of the Chinese-Cantonese version of the Exercise of Self-Care Agency Scale. Int J Nurs Stud 2012;49:1122-1137.
29.
Yu DSF, Lee DTF, Woo J: Issues and challenges of instrument translation. West J Nurs Res 2004;26:307-320.
30.
Portney LG, Watkins MP: Foundations of Clinical Research: Applications to Practice, ed 3. Upper Saddle River, Pearson/Prentice Hall, 2009.
31.
Lam C: Development and validation of a quality of life instrument for older Chinese people in residential care homes. Doctoral dissertation. Hong Kong, The Chinese University of Hong Kong, 2015.
32.
Jones E: Translation of quantitative measures for use in cross-cultural research. Nurs Res 1987;36:324-327.
33.
Lang TA, Secic M: How to Report Statistics in Medicine. Philadelphia, American College of Physicians, 2006.
34.
Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
35.
Lam SC, Ho JKM, Yeung CY, Lee JKL: Psychometric testing of the Chinese version of the Score for Allergic Rhinitis (CSFAR): a screening tool for population-based study. Hong Kong Primary Care Conference 2013. Hong Kong, The Hong Kong College of Family Physicians, 2013.
36.
Streiner DL, Norman GR: Health Measurement Scales, ed 4. New York, Oxford University Press, 2008.
37.
Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, Pribil C, Chanal I: Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy 2005;35:728-732.
38.
Moussu L, Saint-Pierre P, Panayotopoulos V, Couderc R, Amat F, Just J: Determinants of Allergic Rhinitis in Young Children with Asthma. PLoS One 2014;9:e97236.
39.
Asher MI, Stewart AW, Mallol J, Montefort S, Lai CK, Aït-Khaled N, Odhiambo J: Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One. Respir Res 2010;11:8.
40.
D'Amato G, Cecchi L, Bonini S, Nunes C, Annesi-Maesano I, Behrendt H, Van Cauwenberge P: Allergenic pollen and pollen allergy in Europe. Allergy 2007;62:976-990.
41.
Yuen APW, Cheung S, Tang KC, Ho WK, Wong BY, Cheung AC, Ho AC: The skin prick test results of 977 patients suffering from chronic rhinitis in Hong Kong. Hong Kong Med J 2007;13:131-136.
42.
Bunyavanich S, Soto-Quiros ME, Avila L, Laskey D, Senter JM, Celedón JC: Risk factors for allergic rhinitis in Costa Rican children with asthma. Allergy 2010;65:256-263.
43.
Polit DF: Getting serious about test-retest reliability: a critique of retest research and some recommendations. Qual Life Res 2014;23:1713-1720.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.